FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306173873> ?p ?o ?g. }

• W4306173873 endingPage "139729" @default.
• W4306173873 startingPage "139729" @default.
• W4306173873 abstract "Self-delivery bioregulator (C-Moc) is developed through the self-assembly of chlorine e6 (Ce6) and mocetinostat (Moc) in the presence of DSPE-PEG 2000 via intermolecular forces. Carrier free C-Moc could not only inhibit primary tumor growth and induce immunogenic cell death (ICD) by photodynamic therapy (PDT), but also enhance the immune checkpoint-blockade (ICB) therapy by epigenetic reprogramming. • High drug-loading capacity and favorable stability of self-delivery bioregulator. • Positive regulation of MHC-I and PD-L1 by HDAC1 inhibition. • Epigenetic reprogramming of C-Moc reversed immunosuppressive tumor microenvironment. • Primary and distant tumor inhibition by ICB therapy and PDT-induced ICD cascade. Photodynamic therapy (PDT) and immunotherapy have unique advantages for primary and metastatic tumor treatment. However, immunosuppressive tumor microenvironment (ITM) causes low immune responses and various degrees of therapeutic resistance. In this work, a self-delivery bioregulator (C-Moc) is developed for photodynamic amplified immune checkpoint-blockade (ICB) therapy by epigenetic reprogramming. To be specific, carrier-free C-Moc is prepared by the self-assembly of chlorine e6 (Ce6) and mocetinostat (Moc) in the presence of DSPE-PEG 2000 through electrostatic and hydrophobic interactions. Of note, nanosized C-Moc has an improved stability, cellular uptake and pharmacokinetics behaviors. Intravenously injected C-Moc prefers to accumulate at tumor site and then penetrate into tumor tissues upon light irradiation. Meanwhile, the initiated PDT would kill tumor cells for primary tumor inhibition and also induce immunogenic cell death (ICD) to activate antitumor immunity. More importantly, C-Moc is able to increase the expressions of MHC-I and PD-L1 to regulate ITM by epigenetic reprogramming, which would promote the recognition of immune system to MHC-I overexpressed tumor cells and enhance the ICB therapy of α-PD-L1. This photodynamic amplified ICB therapy of C-Moc shows a great superiority over the single treatment on primary and distant tumor suppression." @default.
• W4306173873 created "2022-10-14" @default.
• W4306173873 creator A5000601331 @default.
• W4306173873 creator A5004455301 @default.
• W4306173873 creator A5018655169 @default.
• W4306173873 creator A5026734340 @default.
• W4306173873 creator A5028072443 @default.
• W4306173873 creator A5039567363 @default.
• W4306173873 creator A5043401478 @default.
• W4306173873 creator A5043527719 @default.
• W4306173873 creator A5061455967 @default.
• W4306173873 creator A5064987987 @default.
• W4306173873 date "2023-02-01" @default.
• W4306173873 modified "2023-10-02" @default.
• W4306173873 title "Photodynamic amplified immune checkpoint-blockade therapy of self-delivery bioregulator via epigenetic reprogramming" @default.
• W4306173873 cites W1971208896 @default.
• W4306173873 cites W2024382973 @default.
• W4306173873 cites W2067632426 @default.
• W4306173873 cites W2095224412 @default.
• W4306173873 cites W2095509038 @default.
• W4306173873 cites W2124427232 @default.
• W4306173873 cites W2151467658 @default.
• W4306173873 cites W2292383635 @default.
• W4306173873 cites W2346039915 @default.
• W4306173873 cites W2536322725 @default.
• W4306173873 cites W2578528809 @default.
• W4306173873 cites W2603827936 @default.
• W4306173873 cites W2767373327 @default.
• W4306173873 cites W2785532195 @default.
• W4306173873 cites W2791618607 @default.
• W4306173873 cites W2801287827 @default.
• W4306173873 cites W2804316397 @default.
• W4306173873 cites W2810896552 @default.
• W4306173873 cites W2883164386 @default.
• W4306173873 cites W2885441485 @default.
• W4306173873 cites W2887187316 @default.
• W4306173873 cites W2887577080 @default.
• W4306173873 cites W2892042921 @default.
• W4306173873 cites W2904310948 @default.
• W4306173873 cites W2914335731 @default.
• W4306173873 cites W2924725909 @default.
• W4306173873 cites W2942224185 @default.
• W4306173873 cites W2970548174 @default.
• W4306173873 cites W2975888204 @default.
• W4306173873 cites W2981487371 @default.
• W4306173873 cites W2982753862 @default.
• W4306173873 cites W2999583889 @default.
• W4306173873 cites W3008219687 @default.
• W4306173873 cites W3009193015 @default.
• W4306173873 cites W3015860015 @default.
• W4306173873 cites W3039544508 @default.
• W4306173873 cites W3042379098 @default.
• W4306173873 cites W3091113708 @default.
• W4306173873 cites W3109801031 @default.
• W4306173873 cites W3126492050 @default.
• W4306173873 cites W3160567474 @default.
• W4306173873 cites W3168587734 @default.
• W4306173873 cites W3197878052 @default.
• W4306173873 cites W3198332951 @default.
• W4306173873 cites W3200424637 @default.
• W4306173873 cites W3201778902 @default.
• W4306173873 cites W3211255785 @default.
• W4306173873 cites W4200376172 @default.
• W4306173873 cites W4206168331 @default.
• W4306173873 doi "https://doi.org/10.1016/j.cej.2022.139729" @default.
• W4306173873 hasPublicationYear "2023" @default.
• W4306173873 type Work @default.
• W4306173873 citedByCount "1" @default.
• W4306173873 countsByYear W43061738732023 @default.
• W4306173873 crossrefType "journal-article" @default.
• W4306173873 hasAuthorship W4306173873A5000601331 @default.
• W4306173873 hasAuthorship W4306173873A5004455301 @default.
• W4306173873 hasAuthorship W4306173873A5018655169 @default.
• W4306173873 hasAuthorship W4306173873A5026734340 @default.
• W4306173873 hasAuthorship W4306173873A5028072443 @default.
• W4306173873 hasAuthorship W4306173873A5039567363 @default.
• W4306173873 hasAuthorship W4306173873A5043401478 @default.
• W4306173873 hasAuthorship W4306173873A5043527719 @default.
• W4306173873 hasAuthorship W4306173873A5061455967 @default.
• W4306173873 hasAuthorship W4306173873A5064987987 @default.
• W4306173873 hasConcept C104317684 @default.
• W4306173873 hasConcept C1491633281 @default.
• W4306173873 hasConcept C150194340 @default.
• W4306173873 hasConcept C170493617 @default.
• W4306173873 hasConcept C185592680 @default.
• W4306173873 hasConcept C190727270 @default.
• W4306173873 hasConcept C203014093 @default.
• W4306173873 hasConcept C2777701055 @default.
• W4306173873 hasConcept C2778468042 @default.
• W4306173873 hasConcept C2780737395 @default.
• W4306173873 hasConcept C2780851360 @default.
• W4306173873 hasConcept C41091548 @default.
• W4306173873 hasConcept C55493867 @default.
• W4306173873 hasConcept C71924100 @default.
• W4306173873 hasConcept C77255625 @default.
• W4306173873 hasConcept C86803240 @default.
• W4306173873 hasConcept C8891405 @default.
• W4306173873 hasConceptScore W4306173873C104317684 @default.

• next